Elicio Therapeutics Inc. (ELTX) — Capital Reinvestment Ratio
Elicio Therapeutics Inc. (ELTX) has a Capital Reinvestment Ratio of 0.09x as of June 2022, meaning it reinvests 0% of its operating cash flow ($6.14 Million) in capital expenditures ($559.00K). See how leveraged is Elicio Therapeutics Inc.'s balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Elicio Therapeutics Inc. Capital Reinvestment Ratio (2012–2013)
This chart tracks Elicio Therapeutics Inc.'s Capital Reinvestment Ratio across 2 annual periods. Check total reinvestment intensity of Elicio Therapeutics Inc. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Elicio Therapeutics Inc. (2012–2013)
Year-by-year Capital Reinvestment Ratio for Elicio Therapeutics Inc. from 2012 to 2013. For live market cap and broader valuation context, see Elicio Therapeutics Inc. (ELTX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.01x | $1.89 Million | $17.57K | ▼ -79.3% |
| 2012 | 0.04x | $1.07 Million | $47.73K | — |